These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 14727465)
21. Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile. Fujikawa K; Aratake K; Kawakami A; Aramaki T; Iwanaga N; Izumi Y; Arima K; Kamachi M; Tamai M; Huang M; Nakamura H; Nishiura Y; Origuchi T; Ida H; Eguchi K Ann Rheum Dis; 2007 Jan; 66(1):136-7. PubMed ID: 17178762 [No Abstract] [Full Text] [Related]
22. Successful treatment of genital ulcers with infliximab in Behcet's disease. Haugeberg G; Velken M; Johnsen V Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785 [No Abstract] [Full Text] [Related]
23. Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case. Kram MT; May LD; Goodman S; Molinas S Dis Colon Rectum; 2003 Jan; 46(1):118-21. PubMed ID: 12544532 [TBL] [Abstract][Full Text] [Related]
24. Treatment, management, and monitoring of established rheumatoid arthritis. Bingham CO; Miner MM J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607 [No Abstract] [Full Text] [Related]
26. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease. Park J; Cheon JH Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675 [TBL] [Abstract][Full Text] [Related]
27. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy. Comby E; Tanaff P; Mariotte D; Costentin-Pignol V; Marcelli C; Ballet JJ J Rheumatol; 2006 Jan; 33(1):24-30. PubMed ID: 16395746 [TBL] [Abstract][Full Text] [Related]
28. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195 [TBL] [Abstract][Full Text] [Related]
29. [Infliximab treatment for Behçet's disease--beginning of the biological drug era]. Namba K Nippon Ganka Gakkai Zasshi; 2010 Feb; 114(2):85-6. PubMed ID: 20187504 [No Abstract] [Full Text] [Related]
30. Successful treatment of long-standing neuro-Behçet's disease with infliximab. Sarwar H; McGrath H; Espinoza LR J Rheumatol; 2005 Jan; 32(1):181-3. PubMed ID: 15630746 [TBL] [Abstract][Full Text] [Related]
31. Effect of infliximab on threatening panuveitis in Behçet's disease. Muñoz-Fernández S; Hidalgo V; Fernández-Melón J; Schlincker A; Martín-Mola E Lancet; 2001 Nov; 358(9293):1644. PubMed ID: 11716917 [No Abstract] [Full Text] [Related]
32. Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis. Antoni C; Kalden JR Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S73-7. PubMed ID: 10589362 [TBL] [Abstract][Full Text] [Related]
33. Behçet's syndrome: from aetiology to treatment. Powell RJ Adv Exp Med Biol; 2003; 528():481-6. PubMed ID: 12918749 [No Abstract] [Full Text] [Related]
34. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial. Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571 [TBL] [Abstract][Full Text] [Related]
35. Refractory pseudoseptic arthritis in Behçet's disease successfully treated with infliximab: a case report and literature review. Sifuentes Giraldo WA; Guillén Astete CA; Murillo Romero C; Amil Casas I; Rodríguez García AM; Bachiller Corral FJ Mod Rheumatol; 2014 Jan; 24(1):199-205. PubMed ID: 24261779 [TBL] [Abstract][Full Text] [Related]
36. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha. Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158 [No Abstract] [Full Text] [Related]
37. [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report]. Andreu M; Ramanoelina J; Fajnkuchen F; Mouthon L; Cohen P; Laroche L; Guillevin L Ann Med Interne (Paris); 2002 Oct; 153(6):414-5. PubMed ID: 12486393 [No Abstract] [Full Text] [Related]
39. How does infliximab work in rheumatoid arthritis? Maini RN; Feldmann M Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S22-8. PubMed ID: 12110154 [TBL] [Abstract][Full Text] [Related]